107 related articles for article (PubMed ID: 3085563)
1. The platelet thromboxane inhibitor, dazmegrel, does not reduce monocrotaline-induced pulmonary hypertension.
Langleben D; Carvalho AC; Reid LM
Am Rev Respir Dis; 1986 May; 133(5):789-91. PubMed ID: 3085563
[TBL] [Abstract][Full Text] [Related]
2. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
Langleben D; Reid LM
Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
[TBL] [Abstract][Full Text] [Related]
3. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
Kakusaka I; Kaneko N; Kiyatake K; Fujita A; Suzuki A; Nakano K; Okada O; Sugita T; Watanabe S; Kuriyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548
[TBL] [Abstract][Full Text] [Related]
4. A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension.
Kataoka M; Nagaya N; Satoh T; Itoh T; Murakami S; Iwase T; Miyahara Y; Kyotani S; Sakai Y; Kangawa K; Ogawa S
Am J Respir Crit Care Med; 2005 Dec; 172(12):1575-80. PubMed ID: 16192456
[TBL] [Abstract][Full Text] [Related]
5. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
6. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
7. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs.
Hilliker KS; Bell TG; Roth RA
Thromb Haemost; 1983 Dec; 50(4):844-7. PubMed ID: 6665765
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole.
Ganey PE; Roth RA
Am J Physiol; 1987 Apr; 252(4 Pt 2):H743-8. PubMed ID: 2952022
[TBL] [Abstract][Full Text] [Related]
9. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
Ganey PE; Roth RA
Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
[TBL] [Abstract][Full Text] [Related]
11. Novel approach with intratracheal administration of microgelatin hydrogel microspheres incorporating basic fibroblast growth factor for rescue of rats with monocrotaline-induced pulmonary hypertension.
Hirose K; Marui A; Arai Y; Kushibiki T; Kimura Y; Sakaguchi H; Yuang H; Chandra BI; Ikeda T; Amano S; Tabata Y; Komeda M
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1250-6. PubMed ID: 19026811
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid in pulmonary vascular structural remodeling in rats with pulmonary hypertension induced by monocrotaline.
Qin Y; Zhou A; Ben X; Shen J; Liang Y; Li F
Chin Med J (Engl); 2001 May; 114(5):462-5. PubMed ID: 11780404
[TBL] [Abstract][Full Text] [Related]
13. Single lung transplantation in rats with chemically induced pulmonary hypertension.
Kawaguchi AT; Mizuta T; Matsuda H; Shirakura R; Nakahara K; Tanaka H; Kawashima Y
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):483-9. PubMed ID: 1532040
[TBL] [Abstract][Full Text] [Related]
14. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study.
Todorovich-Hunter L; Johnson DJ; Ranger P; Keeley FW; Rabinovitch M
Lab Invest; 1988 Feb; 58(2):184-95. PubMed ID: 3123799
[TBL] [Abstract][Full Text] [Related]
15. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
Orlinska U; Olson JW; Gillespie MN
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
[TBL] [Abstract][Full Text] [Related]
17. Experimental study on monocrotaline induced pulmonary hypertensive rats. (1) Effect of long-term injection of immunosuppressant.
Tanabe T; Furuya H; Kanemoto N; Goto Y; Hata J
Tokai J Exp Clin Med; 1981 Jan; 6(1):41-8. PubMed ID: 6789505
[TBL] [Abstract][Full Text] [Related]
18. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
[TBL] [Abstract][Full Text] [Related]
19. Serum copper concentration as an index of cardiopulmonary injury in monocrotaline-treated rats.
Molteni A; Ward WF; Ts'ao CH; Fitzsimons EJ
Ann Clin Lab Sci; 1988; 18(6):476-83. PubMed ID: 3149170
[TBL] [Abstract][Full Text] [Related]
20. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
